benzoxazoles has been researched along with leucine in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (9.09) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (54.55) | 24.3611 |
2020's | 4 (36.36) | 2.80 |
Authors | Studies |
---|---|
Evans, DB; Fan, N; Rank, KB; Sharma, SK; Tarpley, WG; Thomas, RC | 1 |
Anzai, N; Endo, H; Endou, H; Hosoda, N; Kanai, Y; Oda, K; Saito, K; Sakata, T; Tsujihara, K; Wempe, MF; Yamamura, M | 1 |
Chun, HS; Endou, H; Kanai, Y; Kim, CS; Kim, DK; Kim, HJ; Kim, JS; Kim, SG; Lee, SA; Oh, JS; Park, MG; Park, MR; Wempe, MF; Yu, SK; Yun, DW | 1 |
Endou, H; Kawada, A; Kimura, T; Ochiai, T; Sakurai, H; Ueno, S; Yamaga, T | 1 |
Anzai, N; Chida, M; Endou, H; Fujita, T; Hayashi, K; Jutabha, P; Maeda, S; Ouchi, M; Supak, Y | 1 |
Anzai, N; Dokduang, H; Endou, H; Hayashi, K; Jutabha, P; Loilome, W; Namwat, N; Sangkhamanon, S; Yongvanit, P; Yothaisong, S | 1 |
Akosman, I; Dosier, LBM; McMahon, TJ; Premkumar, VJ; Wempe, MF; Zhu, H | 1 |
Björkenheim, A; Szabó, B; Sztaniszláv, ÁJ | 1 |
Cronk, S; Dinara, S; Ikhlef, H; Massaro, C; Moots, H; Phanstiel, O; Thomas, J | 1 |
Huttunen, J; Huttunen, KM; Markowicz-Piasecka, M; Montaser, A | 1 |
Anzai, N; Furihata, T; Higuchi, K; Kaneko, M; Morio, H; Muto, Y; Nakagawa, K; Ohno, Y; Okunushi, K; Otsuka, Y; Reien, Y; Sakamoto, S; Shimojo, N; Wakashin, H; Watanabe, Y | 1 |
11 other study(ies) available for benzoxazoles and leucine
Article | Year |
---|---|
Mechanism of resistance to U-90152S and sensitization to L-697,661 by a proline to leucine change at residue 236 of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase.
Topics: Amino Acid Sequence; Antiviral Agents; Base Sequence; Benzoxazoles; Delavirdine; DNA Primers; Drug Resistance, Microbial; HIV Reverse Transcriptase; HIV-1; Indoles; Leucine; Molecular Sequence Data; Piperazines; Point Mutation; Proline; Pyridones; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase | 1995 |
L-type amino acid transporter 1 inhibitors inhibit tumor cell growth.
Topics: Amino Acid Transport System y+; Animals; Antineoplastic Agents; Benzoxazoles; Cell Proliferation; Fusion Regulatory Protein 1, Light Chains; HT29 Cells; Humans; Immunohistochemistry; Intracellular Signaling Peptides and Proteins; Large Neutral Amino Acid-Transporter 1; Leucine; Male; Mice; Mice, Inbred BALB C; Protein Serine-Threonine Kinases; TOR Serine-Threonine Kinases; Tyrosine; Xenograft Model Antitumor Assays | 2010 |
JPH203, an L-type amino acid transporter 1-selective compound, induces apoptosis of YD-38 human oral cancer cells.
Topics: Amino Acid Transport System L; Antineoplastic Agents; Apoptosis; Benzoxazoles; Caspases; Fusion Regulatory Protein 1, Heavy Chain; Humans; Large Neutral Amino Acid-Transporter 1; Leucine; Mouth Neoplasms; Tumor Cells, Cultured; Tyrosine; Up-Regulation | 2014 |
Metformin enhances anti-tumor effect of L-type amino acid transporter 1 (LAT1) inhibitor.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzoxazoles; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Hypoglycemic Agents; Large Neutral Amino Acid-Transporter 1; Leucine; Mechanistic Target of Rapamycin Complex 1; Metformin; Mice, Inbred BALB C; Mice, Nude; Multiprotein Complexes; TOR Serine-Threonine Kinases; Tyrosine | 2016 |
LAT1 acts as a crucial transporter of amino acids in human thymic carcinoma cells.
Topics: Amino Acids; Benzoxazoles; Cell Line, Tumor; Humans; Large Neutral Amino Acid-Transporter 1; Leucine; Thymoma; Thymus Neoplasms; Tyrosine | 2016 |
Inhibition of l-type amino acid transporter 1 activity as a new therapeutic target for cholangiocarcinoma treatment.
Topics: Animals; Apoptosis; Benzoxazoles; Cell Line, Tumor; Cell Proliferation; Cholangiocarcinoma; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; Large Neutral Amino Acid-Transporter 1; Leucine; Mice; Molecular Targeted Therapy; Tyrosine; Xenograft Model Antitumor Assays | 2017 |
Antagonists of the system L neutral amino acid transporter (LAT) promote endothelial adhesivity of human red blood cells.
Topics: Amino Acid Transport System L; Amino Acids, Cyclic; Animals; Benzoxazoles; Cell Adhesion; Cysteine; Endothelial Cells; Erythrocyte Deformability; Erythrocytes; Human Umbilical Vein Endothelial Cells; Humans; In Vitro Techniques; Leucine; Mice; Mice, Nude; Reticulocytes; RNA, Messenger; S-Nitrosothiols; Tyrosine | 2017 |
Hereditary transthyretin amyloidosis caused by the rare Phe33Leu mutation.
Topics: Amyloid Neuropathies, Familial; Benzoxazoles; Combined Modality Therapy; Diagnosis, Differential; Heart Transplantation; Humans; Leucine; Male; Middle Aged; Mutation; Phenylalanine; Prealbumin | 2020 |
Serendipitous Discovery of Leucine and Methionine Depletion Agents during the Search for Polyamine Transport Inhibitors.
Topics: Animals; Benzoxazoles; Biological Transport; CHO Cells; Cricetulus; Drug Discovery; Humans; Large Neutral Amino Acid-Transporter 1; Leucine; Methionine; Polyamines; Putrescine; Small Molecule Libraries; Spermidine; Spermine; Tyrosine | 2020 |
Hemocompatible LAT1-inhibitor can induce apoptosis in cancer cells without affecting brain amino acid homeostasis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzoxazoles; Brain; Brain Chemistry; Carboxylic Acids; Drug Synergism; Gene Expression Regulation, Neoplastic; Human Umbilical Vein Endothelial Cells; Humans; Imidazoles; Injections, Intraperitoneal; Large Neutral Amino Acid-Transporter 1; Leucine; Male; MCF-7 Cells; Mice; Myocytes, Smooth Muscle; NF-kappa B; Norbornanes; Primary Cell Culture; Pyridines; Signal Transduction; Thiazoles; TOR Serine-Threonine Kinases; Tyrosine | 2020 |
JPH203, a newly developed anti-cancer drug, shows a preincubation inhibitory effect on L-type amino acid transporter 1 function.
Topics: Adenocarcinoma; Antineoplastic Agents; Benzoxazoles; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HT29 Cells; Humans; Large Neutral Amino Acid-Transporter 1; Leucine; Time Factors; Tyrosine | 2020 |